By Business/Source
Currency:USD
2021/FY
Stock NameRevenueRatio
Discovering, developing and commercializing antiviral therapeutics351.37M100.00%
By Country/Region
Currency:USD
2021/FY
Stock NameRevenueRatio
United States351.37M100.00%